Author:
Perkušić Mirna,Nižić Nodilo Laura,Ugrina Ivo,Špoljarić Drago,Jakobušić Brala Cvijeta,Pepić Ivan,Lovrić Jasmina,Matijašić Gordana,Gretić Matija,Zadravec Dijana,Kalogjera Livije,Hafner Anita
Reference87 articles.
1. European Medicines Agency. Committee for medicinal products for human use (CHMP): Guideline on the pharmaceutical quality of inhalation and nasal products. 2006. p. 27.
2. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs;Agrawal;J. Control. Release,2018
3. A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: formulation, characterization, and in vitro evaluation;Akel;Int. J. Pharm.,2021
4. 2020 Alzheimer’s disease facts and figures. Alzheimer’s and Dementia 16(3) (2020) 391–460. https://doi.org/10.1002/alz.12068.
5. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil;Asmari al;Drug Des. Dev. Ther.,2016
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献